Early Platelet Indices as Biomarkers of Deep Vein Thrombosis and Prognostic Markers in Mechanically Ventilated ICU Patients
Mean Platelet Volume and Platelet Distribution Width as Early Indicators of Deep Vein Thrombosis and Prognostic Markers in Mechanically Ventilated Intensive Care Unit Patients
1 other identifier
observational
100
0 countries
N/A
Brief Summary
This prospective observational study aims to evaluate the role of mean platelet volume (MPV) and platelet distribution width (PDW) as early indicators of deep vein thrombosis (DVT) and as prognostic markers in mechanically ventilated Intensive Care Unit (ICU) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2025
CompletedFirst Posted
Study publicly available on registry
September 29, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
Study Completion
Last participant's last visit for all outcomes
December 30, 2027
September 29, 2025
September 1, 2025
1.1 years
September 20, 2025
September 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of DVT during ICU stay
Percentage of patients developing DVT as confirmed by Doppler ultrasound during ICU admission
one day
Study Arms (1)
Adult critically ill patients aged ≥18 years admitted to the ICU of Assiut University Hospital who r
The population will consist of mechanically ventilated ICU patients, a group at particularly high risk of thrombotic events due to immobility, systemic inflammation, and sedation, which limit symptom reporting. Eligible participants must be adults (\>18 years) who remain intubated for ≥48 hours.
Eligibility Criteria
he population will consist of mechanically ventilated ICU patients, a group at particularly high risk of thrombotic events due to immobility, systemic inflammation, and sedation, which limit symptom reporting. Eligible participants must be adults (\>18 years) who remain intubated for ≥48 hours. Patients with confounding conditions such as hematological malignancies, congenital platelet disorders, recent platelet transfusions, pre-existing DVT, anticoagulation therapy prior to ICU admission, or pregnancy will be excluded. This selection creates a homogeneous population highly vulnerable to DVT, ideal for assessing the predictive value of MPV and PDW.
You may qualify if:
- Adults ≥18 years
- Admitted to ICU at Assiut University Hospital
- Mechanically ventilated for ≥48 hours
You may not qualify if:
- Known hematological malignancy or platelet disorders
- Recent platelet transfusion within 7 days
- Known pre-existing deep vein thrombosis
- Previous anticoagulation treatment prior to ICU admission
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Zhou Y, Xu Z, Li Z, et al. Mean platelet volume and platelet distribution width as prognostic markers in critically ill patients with sepsis. J Crit Care. 2019;50:213-219. doi:10.1016/j.jcrc.2018.12.003
BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident at the Critical Care Medicine department
Study Record Dates
First Submitted
September 20, 2025
First Posted
September 29, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
September 29, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share